Effectiveness of Digital Marketing Strategies to Improve Adherence to Chronic Medications
e-MedAL
1 other identifier
observational
192
1 country
1
Brief Summary
In the Middle East, particularly Lebanon, the adoption of digital health interventions has been growing. Mobile health (mHealth) platforms, social media campaigns, and telemedicine services are being integrated into healthcare systems. However, while digital marketing for health promotion is gaining traction globally, few studies have specifically examined its impact on medication adherence in Lebanon. The e-MedAL Study aims to fill this gap by evaluating whether tailored digital marketing strategies can foster better adherence among patients with chronic diseases, taking into account the local healthcare infrastructure and cultural context. Lebanon faces unique challenges in managing chronic diseases due to its healthcare system, which is fragmented and highly privatized. The ongoing economic crisis, coupled with the COVID-19 pandemic, has placed additional stress on healthcare delivery, making it difficult for patients to maintain consistent access to medications. Moreover, the high cost of chronic medications, coupled with the population\'s general reliance on out-of-pocket expenditures, contributes to non-adherence. Exploring cost-effective and scalable interventions like digital marketing becomes vital in this context. Lebanon has a high internet and mobile phone penetration rate, which presents an opportunity for leveraging digital tools to promote health. By utilizing culturally tailored messaging and communication strategies, the e-MedAL Study has the potential to improve medication adherence rates significantly. This, in turn, would alleviate the burden on healthcare resources, enhance patient outcomes, and reduce the economic impact of poorly managed chronic diseases in the country. Furthermore, the success of this initiative could serve as a model for other countries in the region facing similar healthcare challenges. Lebanon's diverse and tech-savvy population makes it an ideal test case for assessing the role of digital marketing in healthcare, particularly in resource-constrained settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 15, 2024
CompletedFirst Submitted
Initial submission to the registry
September 11, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedMarch 4, 2025
March 1, 2025
4 months
September 11, 2024
March 3, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Effectiveness of digital marketing strategies
Correlation between the score of the schemes, in addition to some inter-item correlation assessment, as mentioned earlier, and the participants general characteristics.
through study completion, an average of 3 months
Study Arms (1)
Patients
Patients coming to community pharmacies and taking at least the same medication for 6 months
Interventions
Questionnaire to assess the perception and readiness of patients in Lebanon towards the effectiveness of digital marketing strategies to improve their adherence to medications they take chronically The following sections will be considered: * General Characteristics of the Participants * Medical and medication history * Assessment of adherence to chronic medications (Likert scale) * Digital Marketing Strategies to improve adherence to chronic medications (Likert scale) * Perceived barriers to adopting digital marketing strategies in Lebanon (Likert scale)
Eligibility Criteria
Patients from the general population residing in Lebanon and taking the same medication for at least six consecutive months
You may qualify if:
- Patients taking the same medication for at least six months
- Lebanese patients
- Those who agree to participate in the study
You may not qualify if:
- Those with electronic illiteracy
- Those who are not themselves responsible for purchasing the medications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lebanese University
Beirut, 0000, Lebanon
Study Officials
- PRINCIPAL INVESTIGATOR
Georges Hatem
Lebanese University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Clinical and Epidemiological Professor
Study Record Dates
First Submitted
September 11, 2024
First Posted
September 19, 2024
Study Start
July 15, 2024
Primary Completion
November 15, 2024
Study Completion
December 30, 2024
Last Updated
March 4, 2025
Record last verified: 2025-03